Event Highlights
News from Bayer
January 20, 2021
Not intended for U.S. and UK Media
U.S. FDA approves vericiguat for patients with symptomatic chronic heart failure
January 13, 2021
Not intended for U.S. and UK Media - Virtual Bayer Pharma Media Day:
Bayer transforms pharma business through breakthrough innovation in healthcare
January 12, 2021
Not intended for U.S. and UK Media
U.S. FDA grants Priority Review to New Drug Application for finerenone to treat patients with chronic kidney disease and type 2 diabetes
Discover More Investor Resources
